Relationship between CD4 count, viral load, and quality of life in HIV-infected patients on HAART attending a primary healthcare setting in South Africa

Lucky Norah Katende-Kyenda

doi:10.58372/2835-6276.1019

Authors

Lucky Norah Katende-Kyenda

DOI:

https://doi.org/10.58372/2835-6276.1019

Keywords:

CD4 count, Viral load, Quality of Life, PLWHA

Abstract

Background: Biomedical markers remain major measures of HIV/AIDS disease-progression and well-being of people living with HIV (PLWHA) on treatment. It is important to measure health related quality of life (HRQOL) in PLWHA since HIV/AIDS is an incurable chronic disease. Adherence to Antiretroviral therapy (ART) enables PLWHA reach and maintain viral-suppression, reducing risk for secondary-transmission.

Aim: Determine relationship between biomedical-markers and HRQOL among PLWHA on HAART.

Method: A cross-sectional study was conducted in 100 HIV-infected attending an HIV-clinic. Sociodemographic-data were collected using standardized-questionnaire and HRQOL data using WHOQOL-HIV-BREF questionnaire. Biomedical-markers were obtained from patient’s medical-records; ART-adherence from pill-count method. Data were analysed using SPSS-22 for basic descriptive. Independent-samples-test and ANOVA were used to determine significant differences at P ≤ 0.05.

Results: Of 100 participants interviewed, 63% were females, and 37% males with mean-age of 38 years with 36% in age-range 31-40years. Of these, 47% had secondary-education, 20% were contract- employees, 32% receiving ≥ZAR10000 monthly, 55% living in rural-areas and 42% were singles. Good health-status was reported in 92%, 73% had initial-CD4-count ≥500cells/mm³, 54% had initial-viral-load ≥10000copies/mL and 98% undetectable. Asymptomatic patients were 62% and 43% had WHO-clinical-stage-2. Only 24% had acceptable adherence-rate of ≥ 90%. A significant-association was observed between initial-CD4-count and employment-type (F = 4.0905, P = 0.029); income-earned (F = 7.131, P = 0.010); and HIV-status ((F = 4.758. P = 0.032), then initial-viral-load with gender (F = 15.362, P <0.001); educational-level (F = 5.037, P = 0.027) and HIV-status (F = 4.806, P = 0.031). Highest-mean-scores (77.00±14.94) were obtained in environmental and lowest (26.25±26.44) in spiritual/religious/personal beliefs (SRPB) domains. A significant association was between initial-CD4-count and SRPB domain (F=5.473, P = 0.021). There was no association between WHOQOL-HIV domains and initial and current viral loads. Neither was an association between biomedical markers and adherence rates of study participants.

Conclusion: Results reveal no relationship between biomedical-markers and HRQOL in PLWHV. These biomedical markers alone may be inadequate eligibility criteria for social support. Therefore, monitoring these markers should be underscored in the management of HIV patients on HAART. PLWHA on ART will consistently have a huge impact on QOL.

References

Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma Viral Load and CD4+ Lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946-54.

O’Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benolt S, et al. Changes in Plasma HIV-1RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS. N Engl J Med.1996;334(7):426-31. Doi.10.1056/NEJM199602153340703.

MacArthur R, Perez G, Walmsley S, Baxter J, Mullin C, Neaton J, et al. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy. HIV Clin Trials. 2005;(3):127-15.

Blaiss MS. Outcome analysis in asthma. J Amer Med Assoc. 1997; 278:1874-1880.

Kartz PP, Yelin EH, Eisner MD, Gillian E, Blac PD. Performance of valued life activities reflected asthma-specific quality of life more than general physical function. J of Clin Epidem. 2004;57:259-267.

UNAIDS (2017) ‘ending AIDS: Progress towards 90-90-90 targets’ [pdf].

UNAIDS (2019). AIDSinfo.unaids.org.

UNAIDS ‘AIDS info’ (accessed August 2019).

Levi GC, & Vitoria MA. Fighting against AIDS: The Brazilian experience. AIDS. 2002;16(18):2373-83. DOI:101097/00002030.200212060-00001.

WHOQOL-BREF. Introduction, Administration, Scoring and Generic version of the Assessment, Field Trial Version. 1996. WHO. Geneva [homepage on Internet]. No date [cited 2011 May 12]. Available from: http://www.who.int/mental_health/media/en/76.pdf.

Olusina AK, Ohaeri JU. Subjective quality of life of recently discharged Nigerian psychiatric patients. Soc Psychiatric Epidemiol. 2003; 38:707-714. http://dx.doi.org/10.1007/s0012-003-0691-7, PMid:12113267.

OIgumbor J, Stewart A, Holzemer W. Comparison of the health-related quality of life, CD4 count and viral load of AIDS patients and people with HIV who have been on treatment for 12 months in rural South Africa. SAHARA J. 2013;10(1):25-31. Doi: 1080/17290376.2013.807070.Epub 2013 Jun 18

Weinfurt KP, Willke RJ, Freimuth WW, Schulman KA. Relationship between CD4 Count, Viral Burden, and Quality of life Over Time in HIV-1-Infected Patients. Med Care. 2000;38(4):404-10.

Achieng L, Musangi H, Billingsley K, Onguit S, Ombegoh E, Bryant L et al. The Use of Pill Counts as a Facilitator of Adherence with Antiretroviral Therapy in Resource Limited Settings. PLOS one. 2013;8(12) 1-6. www.plosone.org.

Sangeda R, Mosha F, Prosperi M, Aboud S, Vercauteren J. Camacho R, et al. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health; 2014; 14(1):1035.

Fatiregun AA, Mofolorunsho KC, Osagbeni KG. Quality of life of people living with HIV/AIDS in Kogi State, Nigeria. Br PJM; 2009; 11(1).

Stagi AL, Wamai N, Mermini J, Awor AC. Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care. 2007;19(5):626-36. Doi.10.1080/09540120701203915.

Bajunirwe F, Tisch DJ, King CH, Arts EJ, Debanne SM, Sethi AK. Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda. AIDS Care. 2009;21(3):271-9. Doi.10.1080/09540120802241863.

KwaZulu-Natal Department of Health. Strategy of Test and Treat. http://www:Kznhealth.gov.za.

Mutabazi-Mwesigire D, Seely J, Martini F, Katamba A. Perceptions of quality of life among Ugandan patients living with HIV: a qualitative study. BMC.Public Health. 2014;14(1):343.

Oguntibeju OO. QoL of people living with HIV and AIDS and HAART. HIV/AIDS. 2012; 4:117-24.

Surur AS, Teni FS, Tesfaye B. Health related quality of life of HIV/AIDS patients on highly active anti-retroviral therapy at a university referral hospital in Ethiopia. BMC Health Services Research. 2017;17(373) 1-8

Alemu A, Yenealem A, Feleke A, Mesereti S. HQoL assessment and associated factors among people on HAART at Felege Hiwolt referral hospital. J AIDS Clin Res. 2013;35(1):1-5.

Sim J, Wright C. Research in Health Care: Concepts, Designs and Methods. Cheltenham, Stanely Thornes.

Abellan J, Garrote M, Pulido F. Evaluation of adherence to a triple antiretroviral therapy in in HIV-positive patients. EurJ Intern Med. 1999;10:202-205.

Guimaries MDC, Rocha GM, Campos LN, Preitas FMT, Guilberto FAZ, Teixeir RAR et al. Difficulties reported by HIV-infected patients using antiretroviral therapy in Brazil. Clinics. 2008;63(2):165-72.

Zago AM, Morelato P, Endringer EA, Dan GF, Ribeiro EM, Miranda AE. Abondonment of antiretroviral therapy among HIV-positive patients attended at the reference center for HIV/AIDS in Vitoria, Brazil. JIAPAC. 2012;11(1):5-8.